{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:18:35Z","timestamp":1793089115487,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fred S. Rosen Chair Fund"},{"name":"Peter Lehner Family Fund"},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["2P30AR070253."],"award-info":[{"award-number":["2P30AR070253."]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boston Children\u2019s Hospital CHMC Anesthesia Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Juvenile idiopathic arthritis (JIA) is a cluster of autoimmune rheumatic diseases occurring in children 16\u2009years of age or less. While it is well-known that pain may be experienced during inflammatory and non-inflammatory states, much remains ambiguous regarding the molecular mechanisms that may drive JIA pain. Thus, in this pilot study, we explored the variability of the serum proteomes in relation to pain severity in a cohort of JIA patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Serum samples from 15 JIA patients (male and female, 12.7\u2009\u00b1\u20092.8\u2009years of age) were assessed using liquid chromatography\/mass spectrometry (LC\/MS). Correlation analyses were performed to determine the relationships among protein levels and self-reported clinical pain severity. Additionally, how the expression of pain-associated proteins related to markers of inflammation (Erythrocyte Sedimentation Rate (ESR)) or morphological properties of the central nervous system (subcortical volume and cortical thickness) implicated in JIA were also evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>306 proteins were identified in the JIA cohort of which 14 were significantly (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.05) associated with clinical pain severity. Functional properties of the identified pain-associated proteins included but were not limited to humoral immunity (IGLV3.9), inflammatory response (PRG4) and angiogenesis (ANG). Associations among pain-associated proteins and ESR (IGHV3.9, PRG4, CST3, VWF, ALB), as well as caudate nucleus volume (BTD, AGT, IGHV3.74) and insular cortex thickness (BTD, LGALS3BP) were also observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The current proteomic findings suggest both inflammatory- and non-inflammatory mediated mechanisms as potential factors associated with JIA pain. Validation of these preliminary observations using larger patient cohorts and a longitudinal study design may further point to novel serologic markers of pain in JIA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00662-1","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T13:02:27Z","timestamp":1642251747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Hanne","family":"Van Der Heijden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Fatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Sibai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacie","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Lemme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariesa","family":"Cay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Goodlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olha","family":"Halyabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Meidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Ecklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Nigrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Sundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8682-163X","authenticated-orcid":false,"given":"Jaymin","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"issue":"2","key":"662_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"9783","key":"662_CR2","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet Lond Engl. 2011;377(9783):2138\u201349. https:\/\/doi.org\/10.1016\/S0140-6736(11)60244-4.","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"662_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/acr.23327","volume":"70","author":"A Tollisen","year":"2018","unstructured":"Tollisen A, Selvaag AM, Aulie HA, Lilleby V, Aasland A, Lerdal A, et al. Physical functioning, pain, and health-related quality of life in adults with juvenile idiopathic arthritis: a longitudinal 30-year Followup study. Arthritis Care Res. 2018;70(5):741\u20139. https:\/\/doi.org\/10.1002\/acr.23327.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"662_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153267","volume":"11","author":"S Barth","year":"2016","unstructured":"Barth S, Haas J-P, Schlichtiger J, Molz J, Bisdorff B, Michels H, et al. Long-term health-related quality of life in German patients with juvenile idiopathic arthritis in comparison to German general population. PLoS One. 2016;11(4):e0153267. https:\/\/doi.org\/10.1371\/journal.pone.0153267.","journal-title":"PLoS One"},{"issue":"5","key":"662_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/03009742.2019.1596308","volume":"48","author":"K Rebane","year":"2019","unstructured":"Rebane K, Orenius T, Ristolainen L, Relas H, Kautiainen H, Luosuj\u00e4rvi R, et al. Pain interference and associated factors in young adults with juvenile idiopathic arthritis. Scand J Rheumatol. 2019;48(5):408\u201314. https:\/\/doi.org\/10.1080\/03009742.2019.1596308.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"662_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrrheum.2014.4","volume":"10","author":"L La Hausse de Lalouvi\u00e8re","year":"2014","unstructured":"La Hausse de Lalouvi\u00e8re L, Ioannou Y, Fitzgerald M. Neural mechanisms underlying the pain of juvenile idiopathic arthritis. Nat Rev Rheumatol. 2014;10(4):205\u201311. https:\/\/doi.org\/10.1038\/nrrheum.2014.4.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"662_CR7","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/art.10986","volume":"48","author":"LE Schanberg","year":"2003","unstructured":"Schanberg LE, Anthony KK, Gil KM, Maurin EC. Daily pain and symptoms in children with polyarticular arthritis. Arthritis Rheum. 2003;48(5):1390\u20137. https:\/\/doi.org\/10.1002\/art.10986.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"662_CR8","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00431-017-2960-6","volume":"176","author":"F Vanoni","year":"2017","unstructured":"Vanoni F, Minoia F, Malattia C. Biologics in juvenile idiopathic arthritis: a narrative review. Eur J Pediatr. 2017;176(9):1147\u201353. https:\/\/doi.org\/10.1007\/s00431-017-2960-6.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"662_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","volume":"3","author":"G Giancane","year":"2016","unstructured":"Giancane G, Consolaro A, Lanni S, Dav\u00ec S, Schiappapietra B, Ravelli A. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3(2):187\u2013207. https:\/\/doi.org\/10.1007\/s40744-016-0040-4.","journal-title":"Rheumatol Ther"},{"issue":"6","key":"662_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40272-014-0094-0","volume":"16","author":"JE Weiss","year":"2014","unstructured":"Weiss JE, Luca NJC, Boneparth A, Stinson J. Assessment and management of pain in juvenile idiopathic arthritis. Paediatr Drugs. 2014;16(6):473\u201381. https:\/\/doi.org\/10.1007\/s40272-014-0094-0.","journal-title":"Paediatr Drugs"},{"issue":"5","key":"662_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/archdischild-2017-313337","volume":"103","author":"A Rashid","year":"2018","unstructured":"Rashid A, Cordingley L, Carrasco R, Foster HE, Baildam EM, Chieng A, et al. Patterns of pain over time among children with juvenile idiopathic arthritis. Arch Dis Child. 2018;103(5):437\u201343. https:\/\/doi.org\/10.1136\/archdischild-2017-313337.","journal-title":"Arch Dis Child"},{"issue":"11","key":"662_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10067-011-1832-0","volume":"30","author":"E Tarakci","year":"2011","unstructured":"Tarakci E, Yeldan I, Kaya Mutlu E, Baydogan SN, Kasapcopur O. The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol. 2011;30(11):1415\u201320. https:\/\/doi.org\/10.1007\/s10067-011-1832-0.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"662_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11136-016-1468-2","volume":"26","author":"EM Morgan","year":"2017","unstructured":"Morgan EM, Mara CA, Huang B, Barnett K, Carle AC, Farrell JE, et al. Establishing clinical meaning and defining important differences for patient-reported outcomes measurement information system (PROMIS\u00ae) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2017;26(3):565\u201386. https:\/\/doi.org\/10.1007\/s11136-016-1468-2.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"8","key":"662_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.autrev.2015.04.007","volume":"14","author":"E Rochette","year":"2015","unstructured":"Rochette E, Duch\u00e9 P, Merlin E. Juvenile idiopathic arthritis and physical activity: possible inflammatory and immune modulation and tracks for interventions in young populations. Autoimmun Rev. 2015;14(8):726\u201334. https:\/\/doi.org\/10.1016\/j.autrev.2015.04.007.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"662_CR15","first-page":"823","volume":"34","author":"APN Lotito","year":"2007","unstructured":"Lotito APN, Campa A, Silva CAA, Kiss MHB, Mello SBV. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol. 2007;34(4):823\u201330.","journal-title":"J Rheumatol"},{"issue":"5","key":"662_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/ard.2006.061853","volume":"66","author":"W de Jager","year":"2007","unstructured":"de Jager W, Hoppenreijs EPAH, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66(5):589\u201398. https:\/\/doi.org\/10.1136\/ard.2006.061853.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"662_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.autrev.2011.02.001","volume":"10","author":"Y-T Lin","year":"2011","unstructured":"Lin Y-T, Wang C-T, Gershwin ME, Chiang B-L. The pathogenesis of oligoarticular\/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev. 2011;10(8):482\u20139. https:\/\/doi.org\/10.1016\/j.autrev.2011.02.001.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"662_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11926-013-0406-3","volume":"16","author":"CL Duurland","year":"2014","unstructured":"Duurland CL, Wedderburn LR. Current developments in the use of biomarkers for juvenile idiopathic arthritis. Curr Rheumatol Rep. 2014;16(3):406. https:\/\/doi.org\/10.1007\/s11926-013-0406-3.","journal-title":"Curr Rheumatol Rep"},{"key":"662_CR19","doi-asserted-by":"crossref","unstructured":"Husi H, Albalat A. Handbook of Pharmacogenomics and Stratified Medicine. Vols 147\u2013179. 2014.","DOI":"10.1016\/B978-0-12-386882-4.00009-8"},{"issue":"6928","key":"662_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198\u2013207. https:\/\/doi.org\/10.1038\/nature01511.","journal-title":"Nature."},{"issue":"5771","key":"662_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.1124619","volume":"312","author":"B Domon","year":"2006","unstructured":"Domon B, Aebersold R. Mass spectrometry and protein analysis. Science. 2006;312(5771):212\u20137. https:\/\/doi.org\/10.1126\/science.1124619.","journal-title":"Science."},{"key":"662_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jprot.2018.04.004","volume":"190","author":"D Gomez-Varela","year":"2019","unstructured":"Gomez-Varela D, Barry AM, Schmidt M. Proteome-based systems biology in chronic pain. J Proteome. 2019;190:1\u201311. https:\/\/doi.org\/10.1016\/j.jprot.2018.04.004.","journal-title":"J Proteome"},{"key":"662_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jprot.2018.05.012","volume":"190","author":"PE Khoonsari","year":"2019","unstructured":"Khoonsari PE, Ossipova E, Lengqvist J, Svensson CI, Kosek E, Kadetoff D, et al. The human CSF pain proteome. J Proteome. 2019;190:67\u201376. https:\/\/doi.org\/10.1016\/j.jprot.2018.05.012.","journal-title":"J Proteome"},{"issue":"24","key":"662_CR24","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1002\/pmic.201000298","volume":"10","author":"XB Ling","year":"2010","unstructured":"Ling XB, Park JL, Carroll T, Nguyen KD, Lau K, Macaubas C, et al. Plasma profiles in active systemic juvenile idiopathic arthritis: biomarkers and biological implications. Proteomics. 2010;10(24):4415\u201330. https:\/\/doi.org\/10.1002\/pmic.201000298.","journal-title":"Proteomics."},{"key":"662_CR25","doi-asserted-by":"crossref","unstructured":"Brescia AC, Simonds MM, Sullivan KE, Rose CD. Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis. Proteomics Clin Appl. 2017;11(5\u20136).","DOI":"10.1002\/prca.201600088"},{"issue":"12","key":"662_CR26","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","volume":"72","author":"F McErlane","year":"2013","unstructured":"McErlane F, Beresford MW, Baildam EM, et al. Validity of a three-variable juvenile arthritis disease activity score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis. 2013;72(12):1983\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202031.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"662_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.semarthrit.2021.05.011","volume":"51","author":"J Upadhyay","year":"2021","unstructured":"Upadhyay J, Lemme J, Cay M, Van Der Heijden H, Sibai D, Goodlett B, et al. A multidisciplinary assessment of pain in juvenile idiopathic arthritis. Semin Arthritis Rheum. 2021;51(4):700\u201311. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.05.011.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"662_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.15252\/msb.20145625","volume":"10","author":"CS Hughes","year":"2014","unstructured":"Hughes CS, Foehr S, Garfield DA, Furlong EE, Steinmetz LM, Krijgsveld J. Ultrasensitive proteome analysis using paramagnetic bead technology. Mol Syst Biol. 2014;10(10):757. https:\/\/doi.org\/10.15252\/msb.20145625.","journal-title":"Mol Syst Biol"},{"issue":"9","key":"662_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/01.RES.0000146674.38319.07","volume":"95","author":"S Struyf","year":"2004","unstructured":"Struyf S, Burdick MD, Proost P, Van Damme J, Strieter RM. Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4\/CXCL4 and potent inhibitor of angiogenesis. Circ Res. 2004;95(9):855\u20137. https:\/\/doi.org\/10.1161\/01.RES.0000146674.38319.07.","journal-title":"Circ Res"},{"issue":"3","key":"662_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/rheumatology\/kex308","volume":"57","author":"R Raoof","year":"2018","unstructured":"Raoof R, Willemen HLDM, Eijkelkamp N. Divergent roles of immune cells and their mediators in pain. Rheumatol Oxf Engl. 2018;57(3):429\u201340. https:\/\/doi.org\/10.1093\/rheumatology\/kex308.","journal-title":"Rheumatol Oxf Engl"},{"issue":"48","key":"662_CR31","doi-asserted-by":"publisher","first-page":"33481","DOI":"10.1074\/jbc.M114.593129","volume":"289","author":"H L\u00e4ubli","year":"2014","unstructured":"L\u00e4ubli H, Alisson-Silva F, Stanczak MA, Siddiqui SS, Deng L, Verhagen A, et al. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs. J Biol Chem. 2014;289(48):33481\u201391. https:\/\/doi.org\/10.1074\/jbc.M114.593129.","journal-title":"J Biol Chem"},{"issue":"10","key":"662_CR32","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/art.11287","volume":"48","author":"S Ohshima","year":"2003","unstructured":"Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2788\u201395. https:\/\/doi.org\/10.1002\/art.11287.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"662_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1134\/S0006297907050045","volume":"72","author":"TN Kazeeva","year":"2007","unstructured":"Kazeeva TN, Shevelev AB. Unknown functions of immunoglobulins a. Biochem Biokhimiia. 2007;72(5):485\u201394. https:\/\/doi.org\/10.1134\/S0006297907050045.","journal-title":"Biochem Biokhimiia"},{"issue":"11","key":"662_CR34","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1093\/rheumatology\/kew287","volume":"55","author":"B Kirkham","year":"2016","unstructured":"Kirkham B, Chaabo K, Hall C, Garrood T, Mant T, Allen E, et al. Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I\/IIA RAGULA clinical trial in rheumatoid arthritis. Rheumatol Oxf Engl. 2016;55(11):1993\u20132000. https:\/\/doi.org\/10.1093\/rheumatology\/kew287.","journal-title":"Rheumatol Oxf Engl."},{"issue":"1\u20132","key":"662_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jneuroim.2010.10.015","volume":"232","author":"E Staun-Ram","year":"2011","unstructured":"Staun-Ram E, Miller A. Cathepsins (S and B) and their inhibitor cystatin C in immune cells: modulation by interferon-\u03b2 and role played in cell migration. J Neuroimmunol. 2011;232(1\u20132):200\u20136. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.10.015.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"662_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ni888","volume":"4","author":"LV Hooper","year":"2003","unstructured":"Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol. 2003;4(3):269\u201373. https:\/\/doi.org\/10.1038\/ni888.","journal-title":"Nat Immunol"},{"key":"662_CR37","doi-asserted-by":"publisher","first-page":"861435","DOI":"10.1155\/2014\/861435","volume":"2014","author":"SH Lee","year":"2014","unstructured":"Lee SH, Kim KW, Min K-M, Kim K-W, Chang S-I, Kim JC. Angiogenin reduces immune inflammation via inhibition of TANK-binding kinase 1 expression in human corneal fibroblast cells. Mediat Inflamm. 2014;2014:861435\u201312. https:\/\/doi.org\/10.1155\/2014\/861435.","journal-title":"Mediat Inflamm"},{"issue":"1","key":"662_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2249.2003.02117.x","volume":"132","author":"F Liot\u00e9","year":"2003","unstructured":"Liot\u00e9 F, Champy R, Moenner M, Boval-Boizard B, Badet J. Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clin Exp Immunol. 2003;132(1):163\u20138. https:\/\/doi.org\/10.1046\/j.1365-2249.2003.02117.x.","journal-title":"Clin Exp Immunol"},{"key":"662_CR39","doi-asserted-by":"publisher","first-page":"5620314","DOI":"10.1155\/2017\/5620314","volume":"2017","author":"F Gragnano","year":"2017","unstructured":"Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, et al. The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy. Mediat Inflamm. 2017;2017:5620314\u20133. https:\/\/doi.org\/10.1155\/2017\/5620314.","journal-title":"Mediat Inflamm"},{"issue":"5","key":"662_CR40","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.ajpath.2011.07.032","volume":"179","author":"CM Novince","year":"2011","unstructured":"Novince CM, Koh AJ, Michalski MN, Marchesan JT, Wang J, Jung Y, et al. Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells. Am J Pathol. 2011;179(5):2431\u201342. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.032.","journal-title":"Am J Pathol"},{"issue":"1","key":"662_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13075-015-0877-x","volume":"17","author":"A Alquraini","year":"2015","unstructured":"Alquraini A, Garguilo S, D\u2019Souza G, Zhang LX, Schmidt TA, Jay GD, et al. The interaction of lubricin\/proteoglycan 4 (PRG4) with toll-like receptors 2 and 4: an anti-inflammatory role of PRG4 in synovial fluid. Arthritis Res Ther. 2015;17(1):353. https:\/\/doi.org\/10.1186\/s13075-015-0877-x.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"662_CR42","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1038\/s41598-020-61383-7","volume":"10","author":"K Maniwa","year":"2020","unstructured":"Maniwa K, Yano S, Sheikh AM, Onoda K, Mitaki S, Isomura M, et al. Association between cystatin C gene polymorphism and the prevalence of white matter lesion in elderly healthy subjects. Sci Rep. 2020;10(1):4688. https:\/\/doi.org\/10.1038\/s41598-020-61383-7.","journal-title":"Sci Rep"},{"issue":"1","key":"662_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1546-0096-12-28","volume":"12","author":"B H\u00fcgle","year":"2014","unstructured":"H\u00fcgle B, Hinze C, Lainka E, Fischer N, Haas J-P. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course. Pediatr Rheumatol Online J. 2014;12(1):28. https:\/\/doi.org\/10.1186\/1546-0096-12-28.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"662_CR44","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1097\/j.pain.0000000000000694","volume":"157","author":"A Ultsch","year":"2016","unstructured":"Ultsch A, Kringel D, Kalso E, Mogil JS, L\u00f6tsch J. A data science approach to candidate gene selection of pain regarded as a process of learning and neural plasticity. Pain. 2016;157(12):2747\u201357. https:\/\/doi.org\/10.1097\/j.pain.0000000000000694.","journal-title":"Pain."},{"issue":"6","key":"662_CR45","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/j.pain.0000000000001503","volume":"160","author":"S K\u00f6nig","year":"2019","unstructured":"K\u00f6nig S, Bayer M, Dimova V, Herrnberger M, Escolano-Lozano F, Bednarik J, et al. The serum protease network-one key to understand complex regional pain syndrome pathophysiology. Pain. 2019;160(6):1402\u20139. https:\/\/doi.org\/10.1097\/j.pain.0000000000001503.","journal-title":"Pain."},{"issue":"10","key":"662_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/14789450.2017.1366859","volume":"14","author":"S K\u00f6nig","year":"2017","unstructured":"K\u00f6nig S, Schlereth T, Birklein F. Molecular signature of complex regional pain syndrome (CRPS) and its analysis. Expert Rev Proteomics. 2017;14(10):857\u201367. https:\/\/doi.org\/10.1080\/14789450.2017.1366859.","journal-title":"Expert Rev Proteomics"},{"key":"662_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874440001105010001","volume":"5","author":"AP Wunderlich","year":"2011","unstructured":"Wunderlich AP, Klug R, Stuber G, Landwehrmeyer B, Weber F, Freund W. Caudate nucleus and insular activation during a pain suppression paradigm comparing thermal and electrical stimulation. Open Neuroimaging J. 2011;5:1\u20138. https:\/\/doi.org\/10.2174\/1874440001105010001.","journal-title":"Open Neuroimaging J"},{"issue":"1","key":"662_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrn2555","volume":"10","author":"ADB Craig","year":"2009","unstructured":"Craig ADB. How do you feel--now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10(1):59\u201370. https:\/\/doi.org\/10.1038\/nrn2555.","journal-title":"Nat Rev Neurosci"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00662-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00662-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00662-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T13:08:01Z","timestamp":1642252081000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00662-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["662"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00662-1","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Boston Children\u2019s Hospital, Institutional Review Board (IRB-A00028741-7). All patients provided assent to participate in this study, while consent was provided by the patient\u2019s parent or legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}